Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Bruzzese

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Cellular Physiology|February 25, 2003
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cellsElena Di Gennaro, Marcella Barbarino, Francesca Bruzzese, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 8, 2017
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53Manuela Terranova-Barberio, Biagio Pecori, Maria Serena Roca, et al.
Proteomics|July 16, 2011
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cellsLaura Bianchi, Francesca Bruzzese, Alessandra Leone, et al.
Journal of Translational Medicine|June 27, 2022
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer modelsStefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Cancer Research|May 1, 2014
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, et al.
Oncotarget|January 7, 2016
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expressionManuela Terranova-Barberio, Maria Serena Roca, Andrea Ilaria Zotti, et al.
Cell Death & Disease|March 28, 2026
Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancerRita Lombardi, Laura Addi, Biagio Pucci, et al.
Oncotarget|February 11, 2016
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expressionChiara Ciardiello, Maria Serena Roca, Alessia Noto, et al.
Veterinary Sciences|August 28, 2025
Testicular Tumors and Environmental Pollution: A Comparative Oncoepidemiology Study in the Campania Region from 2020 to 2023Evaristo Di Napoli, Davide De Biase, Barbara Degli Uberti, et al.
Molecular Oncology|December 17, 2020
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancerRita Lombardi, Maura Sonego, Biagio Pucci, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cellular Physiology|February 25, 2003
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cellsElena Di Gennaro, Marcella Barbarino, Francesca Bruzzese, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 8, 2017
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53Manuela Terranova-Barberio, Biagio Pecori, Maria Serena Roca, et al.
Proteomics|July 16, 2011
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cellsLaura Bianchi, Francesca Bruzzese, Alessandra Leone, et al.
Journal of Translational Medicine|June 27, 2022
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer modelsStefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Cancer Research|May 1, 2014
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, et al.
Oncotarget|January 7, 2016
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expressionManuela Terranova-Barberio, Maria Serena Roca, Andrea Ilaria Zotti, et al.
Cell Death & Disease|March 28, 2026
Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancerRita Lombardi, Laura Addi, Biagio Pucci, et al.
Oncotarget|February 11, 2016
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expressionChiara Ciardiello, Maria Serena Roca, Alessia Noto, et al.
Veterinary Sciences|August 28, 2025
Testicular Tumors and Environmental Pollution: A Comparative Oncoepidemiology Study in the Campania Region from 2020 to 2023Evaristo Di Napoli, Davide De Biase, Barbara Degli Uberti, et al.
Molecular Oncology|December 17, 2020
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancerRita Lombardi, Maura Sonego, Biagio Pucci, et al.
Pageof 5